CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
66.70
+0.80 (1.21%)
Aug 14, 2025, 3:27 PM - Market open
CVS Health Stock Forecast
Stock Price Forecast
According to 16 professional analysts, the 12-month price target for CVS Health stock ranges from a low of $62 to a high of $84. The average analyst price target of $76.19 forecasts a 14.23% increase in the stock price over the next year.
Price Target: $76.19 (+14.23%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CVS Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 3 | 4 | 4 | 4 |
| Buy | 8 | 8 | 8 | 8 | 8 | 10 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 14 | 15 | 15 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold → Buy Upgrades $71 → $82 | Hold → Buy | Upgrades | $71 → $82 | +22.94% | Aug 14, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $80 → $82 | Buy | Maintains | $80 → $82 | +22.94% | Aug 1, 2025 |
| Barclays | Barclays | Buy Maintains $79 → $80 | Buy | Maintains | $79 → $80 | +19.94% | Aug 1, 2025 |
| UBS | UBS | Hold Maintains $71 → $67 | Hold | Maintains | $71 → $67 | +0.45% | Jul 22, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $74 → $80 | Strong Buy | Maintains | $74 → $80 | +19.94% | Jun 30, 2025 |
Financial Forecast
Revenue This Year
390.68B
from 370.66B
Increased by 5.40%
Revenue Next Year
406.43B
from 390.68B
Increased by 4.03%
EPS This Year
6.20
from 3.66
Increased by 69.27%
EPS Next Year
7.09
from 6.20
Increased by 14.50%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 422.4B | 444.7B | 481.5B | ||
| Avg | 390.7B | 406.4B | 430.9B | ||
| Low | 374.0B | 380.5B | 385.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.0% | 13.8% | 18.5% | ||
| Avg | 5.4% | 4.0% | 6.0% | ||
| Low | 0.9% | -2.6% | -5.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.83 | 8.18 | 9.45 | ||
| Avg | 6.20 | 7.09 | 8.08 | ||
| Low | 5.89 | 5.98 | 6.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 86.5% | 32.0% | 33.2% | ||
| Avg | 69.3% | 14.5% | 13.9% | ||
| Low | 60.9% | -3.5% | -10.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.